In liver cirrhosis, due to endothelial cell damage and stimulation of inflammatory mediators, the expression and release of ET-1 are significantly increased (25), resulting in continuous vasoconstriction and further aggravating of portal hypertension (26). Here, EDN1 is linked to portal hypertension.